Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes

NCT00097877 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00097877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00097877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2005
Completion date
November 30, 2006
Enrollment
293 (actual)
Sites
73

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2